Expert Guidance to Optimize Therapy Decisions for Head and Neck Squamous Cell Carcinoma

This comprehensive program gathers expert insights into the management of patients with locoregionally advanced and metastatic HNSCC, featuring an Interactive Decision Support Tool that lets clinicians compare their treatment choices for specific patient scenarios with those of 5 experts. Also included is a complementary expert-authored module with downloadable slideset with a focus on the most clinically important developments in leveraging checkpoint inhibitors for HNSCC.
Barbara Burtness, MD

Module

Emerging clinical data and expert guidance on checkpoint inhibitors and other treatment options for head and neck squamous cell carcinoma.

Barbara Burtness, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: September 3, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue